Melana Yuzefpolskaya
Overview
Explore the profile of Melana Yuzefpolskaya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
214
Citations
2223
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cali F, Pinsino A, Ladanyi A, Mondellini G, Lee C, Sayer G, et al.
J Card Fail
. 2025 Feb;
PMID: 40021045
No abstract available.
2.
Yuzefpolskaya M, Schwartz S, Ladanyi A, Abraham J, Gale C, Grinstein J, et al.
J Card Fail
. 2025 Jan;
PMID: 39890014
Heart failure (HF) is associated with poor prognosis, especially when it progresses to cardiogenic shock (CS), where survival rates substantially decline. A key area of interest is the role of...
3.
Molinsky R, Shah A, Yuzefpolskaya M, Yu B, Misialek J, Bohn B, et al.
J Am Heart Assoc
. 2025 Jan;
14(3):e033877.
PMID: 39883116
Background: The immune response to infections may become dysregulated and promote myocardial damage contributing to heart failure (HF). We examined the relationship between infection-related hospitalization (IRH) and HF, HF with...
4.
Elad B, Lee C, Rahman A, Rzechorzek W, Defilippis E, Lotan D, et al.
Artif Organs
. 2025 Jan;
PMID: 39835590
Background: GLP-1 RAs improve cardiometabolic outcomes in obese, diabetic, and heart failure patients. Data on the safety and efficacy of GLP-1 RA in advanced heart failure with durable LVAD is...
5.
Prasad N, Harris E, Defilippis E, Sayer G, Chernovolenko M, Colombo P, et al.
J Nucl Med
. 2025 Jan;
66(2):264-270.
PMID: 39819689
Cardiac allograft vasculopathy (CAV) causes impaired blood flow in both epicardial vessels and microvasculature and remains a leading cause of posttransplant morbidity and mortality. This study examined the prognostic value...
6.
Park C, Balkan L, Ringel J, Shikany J, Shikany Dr J, Bostick R, et al.
J Card Fail
. 2025 Jan;
PMID: 39818266
Background: Inflammation plays a key role in the development of heart failure (HF), and diet is a known modifiable factor that modulates systemic inflammation. The dietary inflammatory score (DIS) is...
7.
Kennel P, ODonnell T, Takeda K, Kaku Y, Sayer G, Uriel N, et al.
Ann Thorac Surg Short Rep
. 2025 Jan;
1(4):616-618.
PMID: 39790646
A 67-year-old man with medical history of ischemic cardiomyopathy with stage D heart failure and infrarenal abdominal aortic aneurysm underwent implantation of a left ventricular assist device (LVAD). Three months...
8.
Prasad N, Harris E, Yuzefpolskaya M, Defilippis E, Colombo P, Sayer G, et al.
J Heart Lung Transplant
. 2025 Jan;
PMID: 39743049
Background: Cardiac allograft vasculopathy (CAV) results in impaired blood flow in both epicardial vessels and the microvasculature and is a leading cause of poor outcomes in heart transplant (HT) recipients....
9.
Colombo P, Yuzefpolskaya M
J Heart Lung Transplant
. 2024 Nov;
44(2):246-248.
PMID: 39561863
No abstract available.
10.
Huang X, Yuzefpolskaya M, Colombo P, Choe J, Shertel T, Jennings D
Clin Transplant
. 2024 Nov;
38(11):e70030.
PMID: 39558563
Background: Limited research has compared the relative risks and benefits different statins have after heart transplantation (HT). Method: We hypothesize that higher statin intensity is associated with a smaller degree...